Treatment of Low Bicarbonate (Hypobicarbonatemia)
The treatment for low bicarbonate levels (hypobicarbonatemia) should focus on oral sodium bicarbonate supplementation at a dose of 2-4 g/day (25-50 mEq/day) to maintain serum bicarbonate at or above 22 mmol/L, particularly in patients with chronic kidney disease. 1
Diagnostic Approach
Before initiating treatment, it's essential to determine the cause of low bicarbonate:
- Measure serum bicarbonate monthly in patients with chronic kidney disease (CKD) 1
- Differentiate between metabolic acidosis and respiratory alkalosis as causes of low bicarbonate using:
- Rule out pseudo-hypobicarbonatemia in patients with severe hypertriglyceridemia or paraproteinemia 3
Treatment Algorithm
For Chronic Kidney Disease Patients:
- Target serum bicarbonate level: ≥22 mmol/L 1, 4
- First-line treatment: Oral sodium bicarbonate at 2-4 g/day (25-50 mEq/day) 1
- Monitor serum bicarbonate monthly to adjust dosage 1
- Consider increasing dietary fruits and vegetables as an alternative to sodium bicarbonate supplementation 1
- This approach provides additional benefits including decreased systolic blood pressure and weight reduction 1
For Acute Metabolic Acidosis:
For severe metabolic acidosis (pH <7.1 and bicarbonate <6 mEq/L):
For acidosis due to specific causes:
- Diabetic ketoacidosis: Focus on insulin therapy with fluid resuscitation 5
- Lactic acidosis: Address underlying cause while supporting with bicarbonate if severe 5, 7
- Drug intoxications (barbiturates, salicylates, methyl alcohol): Sodium bicarbonate to enhance elimination 5
- Hemolytic reactions: Sodium bicarbonate to alkalinize urine and reduce nephrotoxicity 5
- Severe diarrhea: Replace bicarbonate losses 5
Benefits of Correcting Acidemia
Correction of metabolic acidosis provides multiple benefits:
- Decreased protein degradation rates 1
- Increased serum albumin levels 1
- Increased plasma concentrations of branched chain amino acids 1
- Improved body weight gain and mid-arm circumference 1
- Reduced hospitalization in continuous peritoneal dialysis patients 1
- Slowed progression of kidney disease in CKD patients 4